IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 3 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,444 | -38.5% | 149,900 | -32.1% | 0.01% | -40.0% |
| Q2 2023 | $2,349 | +256.4% | 220,800 | +252.7% | 0.02% | +200.0% |
| Q1 2023 | $659 | -100.0% | 62,600 | -53.8% | 0.01% | -54.5% |
| Q2 2022 | $1,562,000 | -48.9% | 135,500 | -44.2% | 0.01% | -38.9% |
| Q1 2022 | $3,054,000 | -37.0% | 242,800 | -41.4% | 0.02% | -28.0% |
| Q4 2021 | $4,850,000 | -83.3% | 414,500 | -81.3% | 0.02% | -84.3% |
| Q3 2021 | $28,998,000 | +949.9% | 2,220,400 | +934.7% | 0.16% | +835.3% |
| Q2 2021 | $2,762,000 | +14.6% | 214,600 | -0.5% | 0.02% | +6.2% |
| Q1 2021 | $2,410,000 | -69.0% | 215,600 | -68.4% | 0.02% | -69.8% |
| Q4 2020 | $7,778,000 | +115.3% | 682,900 | +70.0% | 0.05% | +103.8% |
| Q3 2020 | $3,612,000 | +67.3% | 401,600 | +92.0% | 0.03% | +52.9% |
| Q2 2020 | $2,159,000 | +155.2% | 209,200 | +149.6% | 0.02% | +325.0% |
| Q1 2020 | $846,000 | -65.9% | 83,800 | -55.0% | 0.00% | -78.9% |
| Q4 2019 | $2,478,000 | +3.4% | 186,200 | -19.5% | 0.02% | -9.5% |
| Q4 2018 | $2,397,000 | – | 231,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,597,065 | $72,510,000 | 15.06% |
| SOUND ENERGY PARTNERS, INC. | 400,566 | $5,189,000 | 4.02% |
| SECTOR GAMMA AS | 1,138,291 | $14,747,000 | 3.45% |
| Orbimed Advisors | 12,012,100 | $155,617,000 | 1.62% |
| SHAPIRO ROBERT N | 485,974 | $6,296,000 | 1.20% |
| Broderick Brian C | 166,345 | $2,156,000 | 0.96% |
| Hall Kathryn A. | 193,588 | $2,508,000 | 0.65% |
| Tekla Capital Management LLC | 768,050 | $9,950,000 | 0.47% |
| PARADIGM ASSET MANAGEMENT CO LLC | 180,800 | $2,342,264,000 | 0.33% |
| BOURGEON CAPITAL MANAGEMENT LLC | 42,800 | $554,000 | 0.32% |